An Investigational Study to Assess the Effect of BMS-986177 on Aspirin in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 18, 2017

Primary Completion Date

November 16, 2017

Study Completion Date

November 16, 2017

Conditions

Healthy Volunteers

Interventions

DRUG

Aspirin

1 x 325 mg tablet of aspirin administered once daily

DRUG

BMS-986177

200 mg of BMS-986177 administered twice daily

DRUG

Placebo

200 mg of Placebo administered twice daily

Trial Locations (1)

PPD Austin Clinic, Austin